Recruiting An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis NCT06668181 Conditions Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +8 more Locations Ja0005 50646 — Calgary, Canada Ja0005 50644 — Montreal, Canada Ja0005 50645 — Saskatoon, Canada Ja0005 40777 — Indre-et-Loire, France View all 23 locations View more locations Show fewer locations Loading locations... View Trial Details
Not Yet Recruiting A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases. NCT06766552 Conditions Ankylosing Spondylitis (AS), Ankylosis, Aortic Arch Syndromes, +44 more Locations The Second Affiliated Hospital of Zhejiang University — Hangzhou, China View Trial Details
Completed Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA) NCT03031782 Conditions Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +8 more Locations Novartis Investigative Site — Los Angeles, California, United States Novartis Investigative Site — Boise, Idaho, United States Novartis Investigative Site — Cincinnati, Ohio, United States Novartis Investigative Site — Portland, Oregon, United States View all 31 locations View more locations Show fewer locations Loading locations... View Trial Details
